{"store":{"baseInfo":{"podcastTitle":"Sällsynta Podden","slug":"Sallsyntapodden","podcastDescription":"Varmt välkomna att lyssna till podcasten Sällsynta-Podden som sker på initiativ av Takeda. Tillsammans med politiker, hälso- och sjukvårdspersonal och myndighetsrepresentanter diskuterar patientföreträdare olika lösningar på de mest betydande utmaningar som ur deras perspektiv kommer med att leva med en sällsynt sjukdom i Sverige idag.\n\nC-ANPROM/SE/RDG/0050 jan-23","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/15569170/Omslagsbild_S_llsynta_Podden_fyy7gt.jpg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/15569170/Omslagsbild_S_llsynta_Podden_fyy7gt_1200x628.jpg?s=18371a98327680fdd5758a5d440ef93f&e=jpg","podcastUrl":"https://Sallsyntapodden.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/Sallsyntapodden/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pw/pbblog-bp8xk-ed9112?from=usersite","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":31,"gmtAdjustment":"GMT+01:00","useDaylightTime":1,"value":1,"text":"(GMT+01:00) Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna","daylightStartTime":"Last Sunday of March +1 Hours","daylightEndTime":"Last Sunday Of October +1 Hours","timezone":"Europe/London"},"podcastDownloads":null,"totalEpisodes":12,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Sällsynta Podden","enableEngagementStats":true,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-bp8xk-ed9112-playlist","language":"en","sensitivitySessionExpireTime":43200,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/sällsynta-podden/id1659420904","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://www.podbean.com/pw/pbblog-bp8xk-ed9112?from=usersite","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"iHeartRadio","link":"https://iheart.com/podcast/105977650","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/iHeartRadio.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/W6ondbc0puz9","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-Yn1dxbTxYugY","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2022 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"userLikeCheckedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://sallsyntapodden.podbean.com","apiCommonParams":{"t":"684db996","clientSignature":"c239879f27c408a30545cc588d046448","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb20303430-x6m55","episode":{"id":"pb20303430","idTag":"x6m55","title":"Avsnitt 2: Livskvalitet ur ett patientperspektiv – Del 2","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/15569170/Omslagsbild_S_llsynta_Podden_fyy7gt_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/15569170/Omslagsbild_S_llsynta_Podden_fyy7gt_1200x628.jpg?s=18371a98327680fdd5758a5d440ef93f&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/15569170/Omslagsbild_S_llsynta_Podden_fyy7gt.jpg","previewContent":null,"content":"

Avsnitt 2 del 2: Livskvalitet ur ett patientperspektiv

Sällsynta Podden, en ny podcastserie om sällsynta diagnoser. Initiativtagare till podcasten är läkemedelsföretaget Takeda

I podcasten delar patientföreträdare sina erfarenheter av hur det är att leva med en sällsynt sjukdom, både som patient och anhörig.

C-ANPROM/SE/RDG/0032

","publishTimestamp":1673424020,"duration":2871,"mediaUrl":"https://mcdn.podbean.com/mf/web/j4e7yk/2022-09-28_del2_NY2_mixdown.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-x6m55-135ce46","likedCount":1,"deepLink":"https://www.podbean.com/ew/pb-x6m55-135ce46","transcriptUrl":null,"permalink":"/e/sallsynta-podden-avsnitt-2-del-2/","downloadLink":"https://www.podbean.com/media/share/pb-x6m55-135ce46?download=1","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":184,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-x6m55-135ce46","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false,"userIdEncrypted":null,"userProfilePicture":null,"username":null,"isVerified":false,"loadUserInfo":false,"loginUrl":"https://www.podbean.com/site/user/login?return=https%253A%252F%252FSallsyntapodden.podbean.com%252Fe%252Fsallsynta-podden-avsnitt-2-del-2%252F&rts=4d381c106165eb4f2d1fe0d77842fa0ae5f64a9f","recaptchaV3Loaded":false,"recaptchaV2Loaded":false,"likesLoaded":false,"commentLikeMap":{},"commentOffset":0},"episode":{"id":"pb20303430","idTag":"x6m55","title":"Avsnitt 2: Livskvalitet ur ett patientperspektiv – Del 2","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/15569170/Omslagsbild_S_llsynta_Podden_fyy7gt_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/15569170/Omslagsbild_S_llsynta_Podden_fyy7gt_1200x628.jpg?s=18371a98327680fdd5758a5d440ef93f&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/15569170/Omslagsbild_S_llsynta_Podden_fyy7gt.jpg","previewContent":null,"content":"

Avsnitt 2 del 2: Livskvalitet ur ett patientperspektiv

Sällsynta Podden, en ny podcastserie om sällsynta diagnoser. Initiativtagare till podcasten är läkemedelsföretaget Takeda

I podcasten delar patientföreträdare sina erfarenheter av hur det är att leva med en sällsynt sjukdom, både som patient och anhörig.

C-ANPROM/SE/RDG/0032